The number of digital health companies seeking a piece of the remote monitoring market hasn’t diminished investor interest. The cardiac monitoring industry alone is estimated to be worth $3 billion.InfoBionics has completed the first tranche of a $17 million Series B round led by Safeguard Scientifics, according to a company statement. Safeguard’s investment gives it a 20 percent stake in the business and a board seat.
Among other investors in the company are Mass Medical Angels, Broadview Ventures, TiE, Beta Fund, Boardwalk, Launchpad Venture Group, Cherrystone TCA, HTC, Boynton, and Keiretsu.
InfoBionics raised the fresh capital as it prepares to roll out the first application of its Class 2 medical device later this year — detecting cardiac arrhythmias. The platform will also track other chronic conditions.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
The healthcare startup led by Nancy Briefs claims that its cloud-based MoMe System is designed to have a seamless transition between holter, event, and mobile cardiac telemetry monitoring modes, according to a company statement.
Digital medical devices attracted $146 million in venture investment last year, according to a Rock Health report.
